Rho Bio
Rho Bio is a biotechnology company engineering protein therapies that activate the master regulator of the lymphatic system to restore fluid drainage and immune activity. Its lead protein triggers immediate fluid movement and long-term vessel growth while avoiding effects on adjacent vascular systems, targeting diseases linked to lymphatic dysfunction across neurology, cardiology, immunology, and ophthalmology. The company's research is supported by published findings on meningeal lymphatic restoration and synaptic strength.
- Biotechnology
- Drug Discovery & Therapeutics
- Healthcare Technology
Funding
Funding not disclosed
Founders
Founder details are not available yet.
Product
Problem
Lymphatic dysfunction is increasingly linked to serious conditions such as cognitive decline, heart failure, autoimmune disease, and neuro-ophthalmological disorders, yet it remains a vastly underappreciated system in medicine. When the lymphatic system—the body's natural drainage network—falters, fluid and waste build up in tissues, impairing organ function and driving disease progression across multiple organ systems.
Solution
Rho Bio is engineering protein therapies that precisely activate a key signaling axis in the lymphatic system, engaging its master regulator to trigger immediate fluid movement and drive long-term vessel growth. The lead protein strengthens lymphatic drainage and immune activity without affecting adjacent vascular systems, offering a targeted way to address diseases where fluid and waste accumulate in tissues. By treating the lymphatic system as a central driver of disease rather than a bystander, the company aims to develop therapies with broad applicability across organ systems, including neurology, cardiology, immunology, and ophthalmology.
Target Audience
Primary stakeholders are patients with conditions linked to lymphatic dysfunction, including neurological, cardiovascular, autoimmune, and neuro-ophthalmological diseases, as well as the clinicians and researchers treating these conditions.
Features
- Lead protein therapeutic designed to activate the master regulator of lymphatic function
- Dual mechanism of action: immediate fluid movement plus sustained lymphatic vessel growth
- Precision targeting that avoids effects on adjacent vascular systems
- Platform applicable to multiple disease areas: neurology, cardiology, immunology, and ophthalmology
- Research supported by published findings on meningeal lymphatic restoration and synaptic strength